BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30914802)

  • 1. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.
    Penticuff JC; Woolbright BL; Sielecki TM; Weir SJ; Taylor JA
    Nat Rev Urol; 2019 May; 16(5):318-328. PubMed ID: 30914802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
    Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
    Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities.
    Valdez CN; Sánchez-Zuno GA; Bucala R; Tran TT
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
    Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL
    J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system.
    Illescas O; Pacheco-Fernández T; Laclette JP; Rodriguez T; Rodriguez-Sosa M
    Cytokine; 2020 Sep; 133():155121. PubMed ID: 32417648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor (MIF) family in arthropods: Cloning and expression analysis of two MIF and one D-dopachrome tautomerase (DDT) homologues in mud crabs, Scylla paramamosain.
    Huang WS; Duan LP; Huang B; Wang KJ; Zhang CL; Jia QQ; Nie P; Wang T
    Fish Shellfish Immunol; 2016 Mar; 50():142-9. PubMed ID: 26826424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets.
    Günther S; Fagone P; Jalce G; Atanasov AG; Guignabert C; Nicoletti F
    Drug Discov Today; 2019 Feb; 24(2):428-439. PubMed ID: 30439447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
    Panstruga R; Baumgarten K; Bernhagen J
    BMC Evol Biol; 2015 Apr; 15():64. PubMed ID: 25888527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
    Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
    Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways.
    Veillat V; Carli C; Metz CN; Al-Abed Y; Naccache PH; Akoum A
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E403-12. PubMed ID: 20829186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma.
    Cavalli E; Mazzon E; Mammana S; Basile MS; Lombardo SD; Mangano K; Bramanti P; Nicoletti F; Fagone P; Petralia MC
    Brain Sci; 2019 Oct; 9(10):. PubMed ID: 31635049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
    Orita M; Yamamoto S; Katayama N; Fujita S
    Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease.
    Lv J; Huang XR; Klug J; Fröhlich S; Lacher P; Xu A; Meinhardt A; Lan HY
    Clin Sci (Lond); 2013 May; 124(10):627-37. PubMed ID: 23252627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches.
    Petralia MC; Mazzon E; Fagone P; Basile MS; Lenzo V; Quattropani MC; Bendtzen K; Nicoletti F
    J Affect Disord; 2020 Feb; 263():15-24. PubMed ID: 31818772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
    O'Reilly C; Doroudian M; Mawhinney L; Donnelly SC
    Med Res Rev; 2016 May; 36(3):440-60. PubMed ID: 26777977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
    Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
    J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74.
    Djudjaj S; Lue H; Rong S; Papasotiriou M; Klinkhammer BM; Zok S; Klaener O; Braun GS; Lindenmeyer MT; Cohen CD; Bucala R; Tittel AP; Kurts C; Moeller MJ; Floege J; Ostendorf T; Bernhagen J; Boor P
    J Am Soc Nephrol; 2016 Jun; 27(6):1650-64. PubMed ID: 26453615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pathophysiological aspects of macrophage migration inhibitory factor (review).
    Nishihira J
    Int J Mol Med; 1998 Jul; 2(1):17-28. PubMed ID: 9854138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
    Dios A; Mitchell RA; Aljabari B; Lubetsky J; O'Connor K; Liao H; Senter PD; Manogue KR; Lolis E; Metz C; Bucala R; Callaway DJ; Al-Abed Y
    J Med Chem; 2002 Jun; 45(12):2410-6. PubMed ID: 12036350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.